Medication Minute: Sipuleucel-T (Provenge): Immunotherapy for Metastatic Prostate Cancer

Medication Minute: Sipuleucel-T (Provenge): Immunotherapy for Metastatic Prostate Cancer

Identification: unj_ma12_08
Issue: March-April 2012
Volume: Volume 32 Number 2

Standard: $15.00

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.